Skip to main content
. 2009 Apr 27;284(26):17527–17539. doi: 10.1074/jbc.M109.012849

FIGURE 6.

FIGURE 6.

Orthosteric binding site mutants of FFA1 display different responses to rosiglitazone when compared with lauric acid or GW9508X. Cells induced to express wild type (WT) hFFA1-eYFP or each of the individual mutants were then used to monitor potential activation of the ERK1/2 MAP kinases using the SureFire AlphaScreen assay. Response to the ligands was measured at 15 min of stimulation (n = 3). The error bars indicate S.E.